Table 3.
Internal consistency reliably of the PsAID-12, as assessed using week 16 data
| PsAID-12 score | Spearman rank correlation: item-corrected total score* | Cronbach’s alpha: standardised items† |
| PsAID-12 total score | – | 0.95 |
| PsAID-12 pain | 0.85 | 0.95 |
| PsAID-12 fatigue | 0.85 | 0.95 |
| PsAID-12 skin problems | 0.62 | 0.95 |
| PsAID-12 work/leisure activities | 0.89 | 0.94 |
| PsAID-12 functional capacity | 0.90 | 0.94 |
| PsAID-12 discomfort | 0.86 | 0.94 |
| PsAID-12 sleep disturbance | 0.76 | 0.95 |
| PsAID-12 coping | 0.84 | 0.95 |
| PsAID-12 anxiety/fear/uncertainty | 0.58 | 0.95 |
| PsAID-12 embarrassment/shame | 0.57 | 0.95 |
| PsAID-12 social participation | 0.71 | 0.95 |
| PsAID-12 depression | 0.51 | 0.95 |
*p<0.001 for all correlations.
†Cronbach’s alpha was calculated with and without removal of individual PsAID-12 items.
PsAID-12, Psoriatic Arthritis Impact of Disease-12.